Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Nurix Therapeutics Inc (NQ: NRIX )

21.82 -0.23 (-1.04%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,509,127
Open 22.31
Bid (Size) 20.50 (2)
Ask (Size) 23.34 (1)
Prev. Close 22.05
Today's Range 21.06 - 22.79
52wk Range 5.650 - 29.56
Shares Outstanding 47,147,781
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
The Analyst Verdict: Nurix Therapeutics In The Eyes Of 10 Experts
Via Benzinga
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
The Ark Innovation and Ark Genomic ETFs turn ten years old. A look at the annual returns and current top holdings. 
Via Benzinga
Topics ETFs Stocks
Exposures US Equities

Performance

YTD
+113.50%
+113.50%
1 Month
-17.50%
-17.50%
3 Month
-15.06%
-15.06%
6 Month
+40.41%
+40.41%
1 Year
+267.34%
+267.34%

More News

Read More
Wells Fargo To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Boeing, Nurix Therapeutics And 3 Stocks To Watch Heading Into Monday
Via Benzinga
Unveiling 6 Analyst Insights On Nurix Therapeutics
Via Benzinga
Analyst Ratings For Nurix Therapeutics
Via Benzinga
Forecasting The Future: 13 Analyst Projections For Nurix Therapeutics
Via Benzinga
Analyst Scoreboard: 12 Ratings For Nurix Therapeutics
Via Benzinga
This Amazon Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Nvidia’s Earnings Loom In The Summer Stock Snooze-Fest
Via Talk Markets
TJX To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Wednesday
Via Benzinga
Expert Outlook: Nurix Therapeutics Through The Eyes Of 14 Analysts
Via Benzinga
Peeling Back The Layers: Exploring Nurix Therapeutics Through Analyst Insights
Via Benzinga
Key Takeaways From Nurix Therapeutics Analyst Ratings
Via Benzinga
Here Is What You Missed On Wall Street On Friday
Via Talk Markets
Stock Market Weekly Review: Nvidia, AI Chip Plays Hit Resistance
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
Exposures Artificial Intelligence US Equities
Nvidia To Rally Around 53%? Here Are 10 Top Analyst Forecasts For Tuesday
Via Benzinga
What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday?
Via Benzinga
Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Biotech Stock Nurix Therapeutics Jumps On Positive Leukemia Treatment Trial
Via Investor's Business Daily
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Via InvestorPlace
Why JPMorgan Shares Are Trading Lower By Around 5%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Applied Digital Reports Downbeat Results, Joins Nurix Therapeutics And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Why NextPlat Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS